The significance of CD8+ T cells in polyomavirus control is emphasized by studies demonstrating a strong association between an early JCPyV-specific CD8+ T cell response and a favorable clinical outcome in PML patients [276,277]. This evidence concerns the gene CD8A and progressive multifocal leukoencephalopathy.